弗罗斯特雷达：机器人手术设备，2025年

Frost Radar: Robotic Assisted Surgical Devices, 2025

出版日期: 2025年08月29日 | 出版商:

Frost & Sullivan | 英文 22 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

推动公司采取行动的基准化分析系统－推动新交易流程和成长管道的创新

机器人辅助手术设备 (RASD) 透过提高复杂手术的精确度、灵活性和控制力，彻底改变了外科手术实践。机器人技术能够协助外科医生进行人体工学设计、运动缩放和震颤过滤。按服务收费和租赁选项可以缓解对高昂购置和维护成本的担忧。

本分析对领先的供应商进行了基准测试，因为机器人系统的最新创新，例如改进的触觉回馈、整合人工智慧和微型化设计，旨在突破局限性并扩大微创手术的范围。本文重点介绍了机器人辅助手术的变革性作用，并深入探讨了优化其临床应用的未来方向，以及高昂的成本、培训要求以及进一步纵向研究以建立标准化通讯协定的必要性。

Frost & Sullivan 会分析同一产业内的众多公司。我们会根据领导力或其他卓越表现，对入选进行进一步分析的公司进行 10 项成长和创新标准基准测试，以揭示其在 Frost Radar™ 上的排名。这家上市公司会为 Frost Radar™ 上的每一家公司提供竞争概况，探讨每家公司的优势以及与这些优势最契合的机会。

策略要务与成长环境

策略要务

手术机器人公司正在加大对人工智慧 (AI)、机器学习、扩增实境(AR) 和 5G 的投资，以提高手术精度、可视化和远端手术能力。重点是人工智慧辅助机器人，以改善决策并减少错误，而小型移动机器人解决方案则解决了设置时间和成本方面的障碍。
机器人技术可协助外科医生实现人体工学、运动缩放和震颤过滤。各公司正致力于透过扩展培训计画和研讨会（例如 Intuitive Surgical 的奖学金计画）来解决从腹腔镜外科医生过渡到机器人外科医生过程中的陡峭学习曲线。与医院的合作提供了实务经验，从而促进了机器人技术的采用，尤其是在整形外科和研讨会领域。
成功的合併、收购和合作扩大了机器人辅助手术设备 (RASD) 的产品系列和市场份额，例如 Asensus Surgical 收购 KARL STORZ 以及 Stryker 与 Synaptive Medical 合作以增强可视化和手术引导能力。
亚太地区、中东和非洲等高成长地区可能青睐那些提供经济高效的系统和客製化解决方案的公司。Medtronic的Hugo RAS系统等模组化设计可以提高医疗保健支出不断增长的新兴市场的可负担性和可近性。
付费模式和租赁选项，就像在南非部署达文西一样，可以减轻人们对高昂的购买和维护成本的担忧。
Frost & Sullivan 预测，随着医疗设施的去中心化，机器人手术将更加普及。受文明病的增多以及对平价医疗服务需求的不断增长的推动，使用机器人设备的机器人手术正在彻底改变医疗成本的降低方式。

成长环境

美国食品药物管理局(FDA) 的核准和欧洲 CE 标誌认证等法律规范对市场准入和应用有重大影响。不断扩展的监管法规能够扩大临床应用，进而提升整个领域的采用率、收益潜力和创新。这一发展与一个支持性生态系统相吻合，该生态系统的特点是微创手术需求旺盛、人工智慧和机器人技术日益融合、全球人口老化以及医疗保健投资不断增加。
受人口老化和慢性疾病（如癌症和心血管疾病）流行的影响，手术量不断增加，这推动了对系统、仪器和配件的需求增加，从而直接提高了收益。虽然 RASD 在泌尿系统和妇科领域已很成熟，但技术进步和临床证据正在扩展到其他高成长专业，其中神经外科和整形外科最有前景。神经外科中的 RASD 是由人工智慧引导的脑外科手术精准度以及 ROSA ONE Brain 和 ZEISS KINEVO 900 等平台驱动的，而整形外科在关节关节重建和脊柱手术方面继续保持强劲增长，这得益于触觉微钳等创新和退化性疾病的兴起。
像 Intuitive Surgical 这样的老牌公司面临着来自提供创新、低成本系统的竞争对手日益激烈的竞争，这些竞争对手包括 CMR Surgical (Versius)、Asensus Surgical 和 Medtronic (Hugo RAS)。受成本效益和患者偏好的驱动，向门诊手术中心 (ASC) 和门诊设施的转变正在加速。在美国， ASC 每年可节省 380 亿美元的成本。
RASD 广泛应用于关节重建和髋置换术等高精度、微创手术，美国每年进行超过 790,000 例膝关节关节重建和 544,000 例髋置换术。

最佳实践和成长机会

我们的价值主张解决客户痛点，并积极将客户回馈纳入我们的研发和创新中。
经过验证的产品绩效和投资报酬率直接支援客户目标和成功指标，包括提高工作流程效率、品质和财务成果。
我们的人工智慧、机器学习和大规模语言模型等技术能力与行业趋势保持一致，并结合了有机和无机策略。

最佳实践和成长机会

透过整合人工智慧主导的分析和即时数据处理，混合系统可以提升手术精度，超越现有系统。透过将机器人的灵活性与自适应学习能力相结合，这些设备可以减少手术时间并减少人为错误，从而吸引那些希望优化手术结果和手术量的患者和医院。
果冻的范围可以扩大到包括常规手术，一名外科医生可以监督多个手术室，甚至可以进行太空探勘，正如 Space MIRA 在 2024 年测试的那样。人工智慧的整合，正如中国最近的例子所示，表明未来该领域的潜力更大，机器人可以协助甚至部分自动化任务。
借助人工智慧，数据和复杂演算法可以确定模式，并以亚毫米级的精度控制机器人手术。人工智慧和机器视觉可以分析扫描结果，检测出通常会被遗漏的癌症。人工智慧驱动的腹腔镜视讯分析有助于即时识别手术和介入过程中遗漏或意外的步骤。

非公路设备细分

农业机械
农用拖拉机
结合
其他的
打包机
AG割草机
吊具
切碎机
割晒机
施工机械
压实机
起重机
推土机
自动卸货卡车
挖土机
装载机
平土机
搅拌机
铺路车
滚筒
刮刀
加长型堆高机
挖沟机
小型和微型挖土机
紧凑型和小型装载机与先前的展望相比，该系列新增了
矿山机械
压实机
起重机
推土机
自动卸货卡车
挖土机
装载机
平土机
铺路车
滚筒
刮刀
挖沟机

Robotic-assisted surgical devices (RASDs) have transformed surgical practice by enhancing precision, dexterity, and control during complex procedures. Robotic technology helps surgeons in terms of ergonomics, motion scaling, and tremor filtration. Pay-per-use models or leasing options can alleviate concerns about high acquisition and maintenance costs.

This analysis benchmarks leading vendors whose recent innovations in robotic systems, such as improved haptic feedback, artificial intelligence integration, and miniaturized designs, aim to address limitations and expand the scope of minimally invasive surgery. It underscores the transformative role of robotic assistance in surgery and provides insights into future directions for optimizing its clinical application, high costs, training requirements, and the need for further long-term studies to establish standardized protocols.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.

Strategic Imperative and Growth Environment

Strategic Imperative

Surgical robot companies are increasing investments in artificial intelligence (AI), machine learning, augmented reality (AR), and 5G to enhance surgical precision, visualization, and remote surgery (telesurgery) capabilities. The focus is on AI-assisted robots for improving decision-making and reducing errors, while smaller, mobile robotic solutions address setup time and cost barriers.
Robotic technology helps surgeons in terms of ergonomics, motion scaling, and tremor filtration. Companies aim to address the steep learning curve of transitioning from a laparoscopic surgeon to a robotic surgeon by scaling training programs and workshops, such as Intuitive Surgical's fellowship programs. Partnerships with hospitals provide hands-on experience and are boosting adoption, especially in orthopedics and neurosurgery.
Successful mergers, acquisitions, or collaborations expand robotic-assisted surgical device (RASD) product portfolios and market share. Examples include Asensus Surgical's acquisition of KARL STORZ and Stryker's partnerships with Synaptive Medical to enhance capabilities in visualization and surgical guidance.
High-growth regions, such as Asia-Pacific and the Middle East and Africa, can be lucrative for companies that offer cost-effective systems and tailored solutions. Modular designs, such as Medtronic's Hugo RAS system, can improve affordability and accessibility in emerging markets that are spending more on healthcare.
Pay-per-use models or leasing options, as seen with South Africa's Da Vinci adoption, can alleviate concerns about high acquisition and maintenance costs.
Frost & Sullivan expects the decentralization of institutions to bring about more offerings with robotic surgeries. Influenced by the growing incidence of lifestyle diseases and rising demand for affordable healthcare, robotic surgery with robotic devices is transforming the cost of treatment declines.

Growth Environment

Regulatory frameworks, such as US Food and Drug Administration (FDA) approvals or CE mark certifications in Europe, significantly affect market entry and adoption. Regulatory expansions are enabling broader clinical applications, thereby boosting adoption rates, revenue potential, and technological innovation across the sector. This development aligns with a supportive ecosystem characterized by demand for minimally invasive surgeries, advancements in AI and robotics integration, an aging global population, and increasing healthcare investments.
Rising procedure volumes, driven by an aging population and chronic disease prevalence (e.g., cancer and cardiovascular issues) increase demand for systems, instruments, and accessories, directly boosting revenue. While established in urology and gynecology, RASDs are expanding into specialties with high growth potential because of technological enhancements and clinical evidence. The most promising include neurosurgery and orthopedics. RASDs in neurosurgery are driven by AI-guided precision for brain surgeries and platforms like ROSA ONE Brain or ZEISS KINEVO 900, while orthopedics continues to experience strong growth in joint replacements and spine surgeries, supported by innovations such as haptic micro-forceps and an increase in degenerative diseases.
Intuitive Surgical and other established companies face growing competition from new entrants, such as CMR Surgical (Versius), Asensus Surgical, and Medtronic (Hugo RAS), that offer innovative, often lower-cost systems, increasing pricing pressure and making RAS more accessible. The shift to ambulatory surgery centers (ASCs) and outpatient facilities is accelerating, driven by cost-effectiveness and patient preference. ASCs save $38 billion annually in the United States.
RASD are widely used in procedures that benefit from high precision and minimal invasiveness, including knee and hip replacements, with more than 790,000 knee replacements and 544,000 hip replacements performed annually in the United States.

Best Practices & Growth Opportunities

A value proposition addresses client pain points and proactively integrates client feedback in R&D and innovation.
Proven product performance and ROI directly support client goals and success metrics, such as improvements in workflow efficiency, quality, and financial outcomes.
Technological capabilities, such as AI, ML, and large language models, align with industry trends through an appropriate combination of organic and inorganic strategies.

Best Practices & Growth Opportunities

Hybrid systems could integrate AI-driven analytics and real-time data processing to improve surgical precision beyond what current systems offer. By combining robotic dexterity with adaptive learning capabilities, these devices might reduce operative times and human error, appealing to surgeons and hospitals aiming to optimize outcomes and throughput.
Telesurgery's scope could expand to routine procedures in which one surgeon oversees multiple operating rooms, or even to space exploration, as tested with SpaceMIRA in 2024. The integration of AI, as seen in China's recent cases, suggests a future where robots might assist or partially automate tasks, further broadening the field's potential.
With AI, data and complex algorithms can determine patterns to control robots' surgical accuracy to submillimeter precision. AI and machine vision can analyze scans and detect cancerous cases that would otherwise be missed. AI laparoscopic video analysis will help identify missing or unexpected steps in real time during a procedure or intervention.

Segmentation Off-Highway Equipment